E.J. Read

2.3k citations

28 papers · 1.9k indexed · h-index 16

Hematology top 1%
- Hematopoietic Stem Cell Transplantation 14
Immunology top 2%
- T-cell and B-cell Immunology 10
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 7
Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 3
Oncology top 5%
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 2
Genetics top 5%
Molecular Biology
- RNA Interference and Gene Delivery 2

Co-authors: C. Carter Susan F. Leitman Emmanuel Clave Nancy F. Hensel Erkut Bahceci Richard Childs Neal S. Young A. John Barrett
Cited by: Hematology Immunology Transplantation
Journals: Cytotherapy (11 papers)Blood (6 papers)Bone Marrow Transplantation (3 papers)
Partner nations: United States Netherlands Germany

In The Last Decade

E.J. Read

28 papers receiving 1.8k citations

Peers

Countries citing papers authored by E.J. Read

Since Specialization

Citations

This map shows the geographic impact of E.J. Read's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.J. Read with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.J. Read more than expected).

Fields of papers citing papers by E.J. Read

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.J. Read. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.J. Read. The network helps show where E.J. Read may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E.J. Read, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.J. Read Line = papers co-authored together E.J. Read links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A multicenter comparison study between the Endosafe® PTS™ rapid-release testing system and traditional methods for detecting endotoxin in cell-therapy products Cytotherapy ·Adrian P. Gee,Darin Sumstad,Joanna Stanson,P. Massarotti,Morio Miura,신동만,E. Koch,Jenessa Sprague,Deborah Wood,David Styers,David H. McKenna,Joseph F. Gallelli,Dante Avaro,E.J. Read,Tuomas Kara,R. Lindblad	2008	47
2	Multicenter study on in vitro characterization of dendritic cells Cytotherapy ·Hermann Eichler,Xuan Duc Nguyen,Dave L. Roelen,Christina M. Celluzzi,David H. McKenna,DH Pamphilon,Allison Blair,E.J. Read,刘贤,Zbigniew M. Szczepiorkowski	2008	3
3	Development of graft-versus-host disease depends upon establishment of complete donor T cell chimerism after T cell depleted, reduced intensity hematopoietic stem cell transplantation Biology of Blood and Marrow Transplantation ·Nancy M. Hardy,Seth M. Steinberg,Michael Krumlauf,E. Sanakoyeva,Kathleen M. Castro,Frances T. Hakim,Б. Скочинская-Прокопович,E.J. Read,Susan F. Leitman,Ronald E. Gress,Michael R. Bishop	2005	1
4	AMD3100 Mobilized Apheresis Products Are Rich in T-Cells That Do Not Undergo a Th-2 Type Cytokine Polarization: Implications for Allografting. Blood ·Yoshiyuki Takahashi,Abdul Tawab,Roger Kurlander,Mohamed F. Elshal,Charles D. Bolan,E.J. Read,Susan F. Leitman,J. Philip McCoy,Andreas Lundqvist,Erkut Bahceci,Richard Childs	2005	6
5	Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products Cytotherapy ·Hanh Khuu,Frida Stock,Joakim Bergqvist,Liang Ying Lee,V. Lucidi,Jéssica Chagas de Almeida,E.J. Read	2004	26
6	Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside Cytotherapy ·E.J. Read	2004	2
7	A Comparison of Apheresis Cell Content Collected from the Same Donors Mobilized with Granulocyte Colony Stimulating Factor (G-CSF) Vs. a Single Injection of AMD3100. Blood ·MANUEL SOLER MÉNDEZ,Stephen Rydell Malpezzi,E.J. Read,Jacqueline Mary B. Espineli,Shanmugam Karthikeyan,Susan F. Leitman,Charles D. Bolan,Ram Srinivasan,Jorge Martín-Pereira,Gary Calandra,Richard Childs	2004	3
8	A Detailed Phenotypic Analysis Using Six Color Flow Cytometry of Lymphocyte Subsets Mobilized with AMD3100 Compared to G-CSF. Blood ·Yoshiyuki Takahashi,Sakti Chakrabarti,Sulis Aditya,Andreas Lundqvist,E.J. Read,Hanh Khuu,Susan F. Leitman,Charles D. Bolan,A. John Barrett,Gary Calandra,Richard Childs	2004	3
9	Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation Bone Marrow Transplantation ·Scott R. Solomon,Ryotaro Nakamura,E.J. Read,Susan F. Leitman,C. Schleiss,Richard Childs,Cynthia E. Dunbar,Neal S. Young,A. John Barrett	2003	26
10	Going where the action is: cellular therapy for diabetes mellitus Cytotherapy ·E.J. Read	2003	2
11	Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers Cytotherapy ·Eitan Wong,Mary Kathryn Hatcher Jones,Kenneth Hines,Musetti Carola,Yu. A. Sokolovskaya,William Kopp,Julia Glade Bender,E.J. Read	2002	36
12	Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation Cytotherapy ·Scott R. Solomon,Thuong Hien Tran,G. Zhang,Sheila Donnelly,Nancy F. Hensel,John Schindler,Erkut Bahceci,Victor Gheţie,Jaroslav Michálek,Dimitriοs Mavroudis,E.J. Read,E S Vitetta,A. John Barrett	2002	51
13	Phase I clinical trial of donor T-helper Type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant Cytotherapy ·Daniel H. Fowler,Jeannie Hou,Jonathan E. Foley,Fran Hakim,Jeanne Odom,Pingguang Ji,Alexandre A. Mikhailov,E.J. Read,Juan Gea‐Banacloche,Claude Kasten-Sportès,Larry W. Kwak,Wendy Wilson,Bruce L. Levine,Carl H. June,Ronald E. Gress,Michael R. Bishop	2002	12
14	Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences Cytotherapy ·Hanh Khuu,Xenia Kevrekidou,Doug Rubin,류상헌,Claude Kasten-Sportès,Alan S. Wayne,Scott R. Solomon,Michael Bishop,Richard Childs,E.J. Read	2002	27
15	Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy Cytotherapy ·Eitan Wong,V. Ellen Maher,Kenneth Hines,Musetti Carola,Yu. A. Sokolovskaya,Theresa J. Goletz,William Kopp,Crystal L. Mackall,Jay A. Berzofsky,E.J. Read	2001	39
16	Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution? Cytotherapy ·Anne Husebekk,Vicki Fellowes,E.J. Read,Gulzira Madaminova,Tazuko Olson,Ronald E. Gress,Daniel H. Fowler	2000	3
17	T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia Bone Marrow Transplantation ·Philip Hamby,E.J. Read,Jeffrey J. Molldrem,Anastasios Raptis,Michelle Plante,Chilukuri Srija,Sonia Chew Wen Phang,Cynthia E. Dunbar,A. John Barrett	1998	32
18	T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect Bone Marrow Transplantation ·A. John Barrett,Dimitriοs Mavroudis,John F. Tisdale,Jeffrey J. Molldrem,Emmanuel Clave,Cynthia E. Dunbar,Michele Cottler‐Fox,Sonia Chew Wen Phang,C. Carter,G. D Kim,正行新宅,E.J. Read	1998	119
19	Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma. Journal of Clinical Oncology ·Beth Fisher,Beverly S. Packard,E.J. Read,Jorge A. Carrasquillo,C. Carter,T Itoh,Jiacai Yang,Marcin Drzewiecki,Johanes Jonedi Situmorang,S A Rosenberg	1989	261
20	In Vivo Distribution of Adoptively Transferred Indium- 111- Labeled Tumor Infiltrating Lymphocytes and Peripheral Blood Lymphocytes in Patients With Metastatic Melanoma JNCI Journal of the National Cancer Institute ·C.P. van deHart,E.J. Read,Jorge A. Carrasquillo,G. Zhang,James C. Yang,Beth Fisher,Paul Aebersold,Beverly S. Packard,M. Y. Yu,S A Rosenberg	1989	144

About E.J. Read

E.J. Read is a scholar working on Hematology, Transplantation and Immunology, having authored 28 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), T-cell and B-cell Immunology (10 papers), Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (7 papers), Renal Transplantation Outcomes and Treatments (3 papers), CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Hematology (976 citations), Immunology (1.1k citations) and Transplantation (99 citations). E.J. Read has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include C. Carter, Susan F. Leitman, Emmanuel Clave, Nancy F. Hensel, Erkut Bahceci, Richard Childs, Neal S. Young, A. John Barrett, Nathalie Contentin and Beverly S. Packard. Their work appears in journals such as Cytotherapy, Blood, Bone Marrow Transplantation, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact